After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Recently, Yahoo Finance discussed the stock, revealing that PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220C-Positive Solid Tumors.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
PMV Pharmaceuticals Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $1.60 and fluctuated between $1.7300 as its day high and $1.5700 as its day low. The current market capitalization of PMV Pharmaceuticals Inc is $82.30M. A total of 0.65 million shares were traded on the day, compared to an average of 551.29K shares.
In the most recent transaction, ORBIMED ADVISORS LLC sold 87,786 shares of PMVP for 2.23 per share on Nov 22 ’23. After the transaction, the 10% Owner now owns 0 company shares. In a previous transaction on Sep 15 ’23, Alland Leila sold 6,291 shares at 6.62 per share. PMVP shares that Chief Medical Officer owns now total 45,909.
Among the insiders who sold shares, Jalota Deepika disposed of 4,104 shares on Sep 15 ’23 at a per-share price of $6.62. This resulted in the Chief Development Officer holding 29,946 shares of PMVP after the transaction.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, PMVP has a high of $9.72 and a low of $1.17.
As of this writing, PMVP has an earnings estimate of -$0.37 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of -$0.29 per share and a lower estimate of -$0.46. The company reported an EPS of -$0.34 in the last quarter, which was 24.40% higher than expectations of -$0.45.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. PMVP’s latest balance sheet shows that the firm has $297.16M in Cash & Short Term Investments as of fiscal 2021. There were $11.19M in debt and $12.22M in liabilities at the time. Its Book Value Per Share was $4.39, while its Total Shareholder’s Equity was $308.56M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PMVP is Buy with a score of 4.50.
